🇺🇸 FDA
Patent

US 9683025

Methods and compositions for treating cancer and inflammatory diseases

granted A61KA61K38/00A61P

Quick answer

US patent 9683025 (Methods and compositions for treating cancer and inflammatory diseases) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P29/00, A61P35/00